Item


Glycan Characterization of PSA 2-DE Subforms from Serum and Seminal Plasma

Prostate-specific antigen (PSA) two-dimensional electrophoresis (2-DE) subforms (F1–F5) have been described to be altered in prostate cancer (PCa) compared to benign prostatic hyperplasia (BPH). To understand their molecular differences, characterization of these subforms from PCa serum and seminal plasma, namely, at the glycan level, was performed. PSA 2-DE subforms from two serum PCa samples and seminal plasma were analyzed by N-glycan sequencing using high-performance liquid chromatography (HPLC) combined with exoglycosidase array digestions and by mass spectrometry. F1, F2, and F3 subforms showed the same N-glycan pattern, which contained higher levels of sialic acid than the F4 subform, whereas the F5 subform was unglycosylated. When comparing PSA subforms from PCa with seminal plasma, a decrease in sialylation was observed. Furthermore, the analysis of F3, the more abundant PSA subform, showed a higher proportion of alpha 2–3 sialic acid and a decrease in core fucosylated glycans in the PCa sample. These N-glycan changes in PCa PSA subforms highlight the importance of glycosylation as an indicator of PCa disease

© OMICS A Journal of Integrative Biology, 2010, vol. 14, núm. 4, p. 465-474

Mary Ann Liebert, Inc

Author: Sarrats Carbó, Ariadna
Saldova, Radka
Comet i Batlle, Josep
O’Donoghue, Niaobh
Llorens Duran, Rafael de
Rudd, Pauline M.
Peracaula Miró, Rosa
Date: 2010
Abstract: Prostate-specific antigen (PSA) two-dimensional electrophoresis (2-DE) subforms (F1–F5) have been described to be altered in prostate cancer (PCa) compared to benign prostatic hyperplasia (BPH). To understand their molecular differences, characterization of these subforms from PCa serum and seminal plasma, namely, at the glycan level, was performed. PSA 2-DE subforms from two serum PCa samples and seminal plasma were analyzed by N-glycan sequencing using high-performance liquid chromatography (HPLC) combined with exoglycosidase array digestions and by mass spectrometry. F1, F2, and F3 subforms showed the same N-glycan pattern, which contained higher levels of sialic acid than the F4 subform, whereas the F5 subform was unglycosylated. When comparing PSA subforms from PCa with seminal plasma, a decrease in sialylation was observed. Furthermore, the analysis of F3, the more abundant PSA subform, showed a higher proportion of alpha 2–3 sialic acid and a decrease in core fucosylated glycans in the PCa sample. These N-glycan changes in PCa PSA subforms highlight the importance of glycosylation as an indicator of PCa disease
Format: application/pdf
ISSN: 1536-2310 (versió paper)
1557-8100 (versió electrònica)
Document access: http://hdl.handle.net/10256/7483
Language: eng
Publisher: Mary Ann Liebert, Inc
Collection: Reproducció digital del document publicat a: http://dx.doi.org/10.1089/omi.2010.0050
Articles publicats (D-B)
Is part of: © OMICS A Journal of Integrative Biology, 2010, vol. 14, núm. 4, p. 465-474
Rights: Tots els drets reservats. This is a copy of an article published in the OMICS A Journal of Integrative Biology © 2010 Mary Ann Liebert, Inc.; OMICS A Journal of Integrative Biology is available online at: http://www.liebertonline.com.
Subject: Pàncrees -- Càncer -- Investigació
Pancreas -- Cancer -- Research
Glicoproteïnes
Glycoproteins
Antígen prostàtic específic
Prostate-specific antigen
Title: Glycan Characterization of PSA 2-DE Subforms from Serum and Seminal Plasma
Type: info:eu-repo/semantics/article
Repository: DUGiDocs

Subjects

Authors


Warning: Unknown: write failed: No space left on device (28) in Unknown on line 0

Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/var/lib/php5) in Unknown on line 0